Expression and Characterization of a Potent Long-Acting GLP-1 Receptor Agonist, GLP-1-IgG2σ-Fc.

Human GLP-1 (glucagon-like peptide-1) can produce a remarkable improvement in glycemic control in patients with type 2 diabetes. However, its clinical benefits are limited by its short half-life, which is less than 2 min because of its small size and rapid enzymatic inactivation by dipeptidyl peptid...

Full description

Bibliographic Details
Main Authors: Yi Yang, Fang Chen, Deyou Wan, Yunhui Liu, Li Yang, Hongru Feng, Xinling Cui, Xin Gao, Haifeng Song
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4883776?pdf=render

Similar Items